Formulation and Quality – Chemical
2019 PharmSci 360
At Fluid Pharma, we have developed the MicroCoat™ technology to manufacture coated microparticles at industrial scale. This technology allows for rapid and cost-effective development of patient-centric medication for paediatric and geriatric patients. The beneficial feature of the technology include: 1) Smart, simple, scalable technology to produce functional microparticles; 2) Innovative process engineering in fluidised bed coating; 3) Microparticle size range controllable between 150 - 250 µm; 4) optimal for liquid suspension ; 5) Applicable for taste-masking, GI targeting and controlled release and 6) Narrow, discrete size range not achievable using any other functional coating technologies.